Showing results (81-90 of 463) with videos related to
Sort By:
Pageof 47
Clinical Chemistry|September 27, 2002
CYP3A5 variant allele frequencies in Dutch CaucasiansRon H N van Schaik, Ilse P van der Heiden, John N van den Anker, et al.Cancer Biology & Therapy|June 16, 2006
Influence of high-dose ketoconazole on the pharmacokinetics of docetaxelFrederike K Engels, Ron A A Mathot, Walter J Loos, et al.BMC Medicine|November 14, 2009
Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trialCamiel Verhamme, Rob J de Haan, Marinus Vermeulen, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|June 26, 2014
Do Asian renal transplant patients need another mycophenolate mofetil dose compared with Caucasian or African American patients?Pengmei Li, Nauras Shuker, Dennis A Hesselink, et al.Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology|January 29, 2025
Metagenomics education in a modular CURE format positively affects students' scientific discovery perception and data analytical skillsM C Morsink, E N van Schaik, K Bossers, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|October 15, 2011
ATP-binding cassette transporters as pharmacogenetic biomarkers for kidney transplantationNauras Shuker, Rachida Bouamar, Willem Weimar, et al.Pharmacogenetics and Genomics|March 6, 2012
The new CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with an increased risk of delayed graft function and worse renal function in cyclosporine-treated kidney transplant patientsLaure Elens, Rachida Bouamar, Dennis A Hesselink, et al.Cancer Chemotherapy and Pharmacology|January 27, 2007
Influence of ketoconazole on the fecal and urinary disposition of docetaxelFrederike K Engels, Walter J Loos, Ron A A Mathot, et al.Journal of Clinical Psychopharmacology|June 18, 2013
Association between genetic variation in the ABCB1 gene and switching, discontinuation, and dosage of antidepressant therapy: results from the Rotterdam StudyRaymond Noordam, Nikkie Aarts, Albert Hofman, et al.Critical Care (London, England)|January 22, 2014
Neurofilaments as a plasma biomarker for ICU-acquired weakness: an observational pilot studyLuuk Wieske, Esther Witteveen, Axel Petzold, et al.Pageof 47